Shane Fernandez

ORCID: 0000-0002-4881-245X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Associations and Epidemiology
  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Epigenetics and DNA Methylation
  • Advanced Neuroimaging Techniques and Applications
  • Bioinformatics and Genomic Networks
  • Cardiovascular Health and Disease Prevention
  • Tryptophan and brain disorders
  • Functional Brain Connectivity Studies
  • Cancer-related gene regulation
  • Neurological Disease Mechanisms and Treatments
  • Genetic Syndromes and Imprinting
  • Advanced MRI Techniques and Applications
  • Diabetes and associated disorders

Edith Cowan University
2017-2024

Australian Alzheimer’s Research Foundation
2021

Genetic association studies have identified 44 common genome-wide significant risk loci for late-onset Alzheimer's disease (LOAD). However, LOAD genetic architecture and prediction are unclear. Here we estimate the optimal P-threshold (P

10.1038/s41467-020-18534-1 article EN cc-by Nature Communications 2020-09-23

Aging and Alzheimer's disease (AD) are associated with progressive brain disorganization. Although structural asymmetry is an organizing feature of the cerebral cortex it unknown whether continuous age- AD-related cortical degradation alters asymmetry. Here, in multiple longitudinal adult lifespan cohorts we show that higher-order regions exhibiting pronounced at age ~20 also asymmetry-loss across lifespan. Hence, accelerated thinning (previously) thicker homotopic hemisphere a aging. This...

10.1038/s41467-021-21057-y article EN cc-by Nature Communications 2021-02-01
Steve Pedrini Veer Bala Gupta Eugene Hone James D. Doecke Sid E. O’Bryant and 95 more Ian James Ashley I. Bush Christopher C. Rowe Victor L. Villemagne David Ames Colin L. Masters Ralph N. Martins Greg Savage Bill Wilson Pierrick Bourgeat Jürgen Fripp Simon Gibson Hugo Leroux Simon McBride Olivier Salvado Michael Fenech Maxime François Mary Barnes Jenalle E. Baker Kevin J. Barnham Shayne A. Bellingham Julia Bomke Sveltana Bozin Pejoska Rachel F. Buckley Lesley Cheng Steven Collins Ian Cooke Elizabeth Cyarto David Darby Vincent Doré Denise El-Sheikh Noel G. Faux Christopher Fowler Karra Harrington Andy Hill Malcolm Horne Gareth Jones Adrian Kamer Neil Killeen Hannah Korrel Fiona Lamb Nicola T. Lautenschlager Kate Lennon Qiao‐Xin Li Yen Ying Lim Andrea Louey Lance Macaulay Lucy Mackintosh Paul Maruff Alissandra Mcilroy Julie Nigro Kayla Perez Kelly K. Pertile Carolina Restrepo Bárbara Rita Cardoso Alan Rembach Blaine R. Roberts Jo Robertson Rebecca Rumble Tim Ryan Jack Sach Brendan Silbert Christine Thai Brett Trounson Irene Volitakis Michael Vovos Larry D. Ward Andrew D. Watt Rob Williams Mark Woodward Paul Yates Fernanda Yevenes Ugarte Ping Zhang Sabine Bird Belinda M. Brown Samantha Burnham Pratishtha Chatterjee Kay L. Cox Shane Fernandez Binosha Fernando Samantha L. Gardener Simon M. Laws Florence Lim Lucy Lim Michelle Tegg Kathy Lucas Georgia Martins Tenielle Porter Stephanie R. Rainey‐Smith Mark Rodrigues Kaikai Shen Hamid R. Sohrabi Kevin Taddei Tania Taddei Sherilyn Tan

Abstract Alzheimer’s Disease (AD) is the most common form of dementia, characterised by extracellular amyloid deposition as plaques and intracellular neurofibrillary tangles tau protein. As no current clinical test can diagnose individuals at risk developing AD, aim this project to evaluate a blood-based biomarker panel identify who carry risk. We analysed levels 22 biomarkers in clinically classified healthy controls (HC), mild cognitive impairment (MCI) participants from well Australian...

10.1038/s41598-017-14020-9 article EN cc-by Scientific Reports 2017-10-19

Abstract Epigenome-wide association studies (EWAS) are susceptible to widespread confounding caused by population structure and genetic relatedness. Nevertheless, kinship estimation is challenging in EWAS without genotyping data. Here, we proposed MethylGenotyper, a method that for the first time enables accurate at thousands of single nucleotide polymorphisms (SNPs) directly from commercial DNA methylation microarrays. We modeled intensities probes near SNPs with mixture three beta...

10.1093/gpbjnl/qzae044 article EN cc-by Genomics Proteomics & Bioinformatics 2024-06-01

Abstract. Background: Genetic variation in Spondin-1, specifically rs11023139, has been associated with reduced rates of cognitive decline individuals Alzheimer’s disease. Objective: The aim this study was to assess whether the association present cognitively normal older adults. Methods: Longitudinal investigated using linear mixed modelling a cohort 590 adults enrolled Australian Imaging, Biomarkers and Lifestyle Study. Results: No independent effect Spondin-1 rs11023139 on observed....

10.3233/adr-200246 article EN cc-by-nc Journal of Alzheimer s Disease Reports 2021-02-09

Abstract Epigenome-wide association studies (EWAS) are susceptible to widespread confounding caused by population structure and genetic relatedness. Nevertheless, kinship estimation is challenging in EWAS without genotyping data. We propose MethylGenotyper, a method that for the first time enables accurate at thousands of SNPs directly from commercial DNA methylation microarrays. model intensities probes near with mixture three beta distributions corresponding different genotypes estimate...

10.1101/2024.04.15.589670 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-04-17

Abstract Background Genome‐wide association studies (GWAS) have identified numerous genetic variants associated with Alzheimer’s disease (AD) risk, but variation in the onset and progression of AD pathology is less understood. Accumulation amyloid‐β (Aβ) brain a key pathological hallmark beginning 10 – 20 years prior to cognitive symptoms. We investigated basis age at (AAO) Aβ by comparing performance polygenic scores (PGSs) based on risk resilience Aβ‐AAO trait‐specific PGS. Method 1122...

10.1002/alz.090024 article EN cc-by Alzheimer s & Dementia 2024-12-01

Abstract Background World‐Wide FINGERS (WW‐FINGERS) is a global network of multidomain lifestyle intervention trials for dementia risk reduction and prevention (Kivipelto et al., 2020). With over 30 countries conducting studies within the network, harmonizing interventions data collection wherever possible priority. However, study‐specific adaptations are inevitable to accommodate differences in language, culture, environment. Thus, single system not feasible across WW‐FINGERS opportunities...

10.1002/alz.050355 article EN Alzheimer s & Dementia 2021-12-01
Coming Soon ...